Jyothy Labs Limited (JYOTHYLAB.BO)
INR 381.1
(-0.68%)
INR 381.1
(-0.68%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 505.6 Million INR | 8.65% |
| 2022 | 465.35 Million INR | -72.82% |
| 2021 | 1.71 Billion INR | 2.84% |
| 2020 | 1.66 Billion INR | -50.37% |
| 2019 | 3.35 Billion INR | 20.18% |
| 2018 | 2.79 Billion INR | -48.53% |
| 2017 | 5.42 Billion INR | 9.24% |
| 2016 | 4.96 Billion INR | 10.12% |
| 2015 | 4.5 Billion INR | -20.82% |
| 2014 | 5.69 Billion INR | 6.89% |
| 2013 | 5.32 Billion INR | -14.9% |
| 2012 | 6.25 Billion INR | 10.59% |
| 2011 | 5.65 Billion INR | 719.55% |
| 2010 | 690.6 Million INR | 429.23% |
| 2009 | 130.49 Million INR | 0.0% |
| 2007 | 5.17 Million INR | -33.38% |
| 2006 | 7.76 Million INR | 559.9% |
| 2005 | 1.17 Million INR | 248.22% |
| 2004 | 338 Thousand INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 505.6 Million INR | 8.65% |
| 2023 Q2 | 448.4 Million INR | 0.0% |
| 2023 Q4 | 505.6 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 465.35 Million INR | 0.0% |
| 2022 Q2 | 1.59 Billion INR | 0.0% |
| 2022 FY | 465.35 Million INR | -72.82% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.71 Billion INR | 2.84% |
| 2021 Q2 | 1.58 Billion INR | 0.0% |
| 2021 Q4 | 1.71 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 1.66 Billion INR | 0.0% |
| 2020 FY | 1.66 Billion INR | -50.37% |
| 2020 Q2 | 1.67 Billion INR | 0.0% |
| 2019 Q4 | 3.35 Billion INR | 0.0% |
| 2019 FY | 3.35 Billion INR | 20.18% |
| 2019 Q2 | 2.74 Billion INR | 0.0% |
| 2018 FY | 2.79 Billion INR | -48.53% |
| 2018 Q4 | 2.79 Billion INR | 0.0% |
| 2017 FY | 5.42 Billion INR | 9.24% |
| 2017 Q4 | 5.42 Billion INR | 0.0% |
| 2017 Q2 | 1.84 Billion INR | 0.0% |
| 2016 Q2 | 514 Million INR | 0.0% |
| 2016 FY | 4.96 Billion INR | 10.12% |
| 2016 Q4 | 4.96 Billion INR | 0.0% |
| 2015 Q4 | 4.5 Billion INR | 0.0% |
| 2015 FY | 4.5 Billion INR | -20.82% |
| 2015 Q2 | 4.48 Billion INR | 0.0% |
| 2014 Q4 | 5.69 Billion INR | 0.0% |
| 2014 FY | 5.69 Billion INR | 6.89% |
| 2014 Q2 | 5.31 Billion INR | 0.0% |
| 2013 FY | 5.32 Billion INR | -14.9% |
| 2013 Q4 | 5.32 Billion INR | 0.0% |
| 2012 FY | 6.25 Billion INR | 10.59% |
| 2011 FY | 5.65 Billion INR | 719.55% |
| 2010 FY | 690.6 Million INR | 429.23% |
| 2009 FY | 130.49 Million INR | 0.0% |
| 2007 FY | 5.17 Million INR | -33.38% |
| 2006 FY | 7.76 Million INR | 559.9% |
| 2005 FY | 1.17 Million INR | 248.22% |
| 2004 FY | 338 Thousand INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ador Multiproducts Limited | 10.16 Million INR | -4874.909% |
| Ambica Agarbathies Aroma & Industries Limited | 673.21 Million INR | 24.897% |
| Bajaj Consumer Care Limited | 87.51 Million INR | -477.763% |
| Colgate-Palmolive (India) Limited | 717.5 Million INR | 29.533% |
| Cupid Limited | 120.58 Million INR | -319.289% |
| Dabur India Limited | 13.65 Billion INR | 96.296% |
| Emami Limited | 939.5 Million INR | 46.184% |
| Gillette India Limited | 500 Thousand INR | -101020.0% |
| Godrej Consumer Products Limited | 32.22 Billion INR | 98.431% |
| Hindustan Unilever Limited | 14.84 Billion INR | 96.593% |
| Hipolin Limited | 20.82 Million INR | -2328.201% |
| Honasa Consumer Limited | 1.3 Billion INR | 61.395% |
| JHS Svendgaard Laboratories Limited | 51.28 Million INR | -885.825% |
| Kaya Limited | 3.01 Billion INR | 83.229% |
| Marico Limited | 5.28 Billion INR | 90.424% |
| N.K Industries Limited | - INR | -Infinity% |
| PAOS INDUSTRIES LIMITED | 163.74 Million INR | -208.773% |
| Paramount Cosmetics (India) Limited | 122.03 Million INR | -314.301% |
| Pee Cee Cosma Sope Limited | 15.14 Million INR | -3237.734% |
| Procter & Gamble Hygiene and Health Care Limited | 30.8 Million INR | -1541.558% |